---
figid: PMC8224563__medicina-57-00522-g001
figtitle: Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium
  tuberculosis Infection
organisms:
- Mycobacterium tuberculosis
- Homo sapiens
pmcid: PMC8224563
filename: medicina-57-00522-g001.jpg
figlink: /pmc/articles/PMC8224563/figure/medicina-57-00522-f001/
number: F1
caption: 'Regulatory mechanism of autophagy pathway and potential targets ofdifferent
  host directed therapeutic drugs. (): Activation, ():inhibition, (): Drug induced
  activation, (): Drug induced inhibition, (): Upregulation, (): Downregulation, ():
  Drug induced upregulation, (): Blocks activation process, Numbers in blue boxes
  indicate drug induced activation of the following processes—1: Increased autophagosome
  formation (SMER 18 & 28, nortriptyline); 2: AMPK activation: (AICAR, ornithine,
  metformin, statins); 3: TFEB signaling upregulation (GSK4112, GW7647, trehalose,
  Wy14643, honokiol, ambroxol); 4: SIRT 1, 3 activator (SRT 1720, resveratrol, honokiol);
  5: Ca2+—AMPK signaling (GABA, vitamin D, soyabean lectin, isoniazid, pyrazinamide,
  calcimycin); 6: mTOR inhibition (Rapamycin, evorilimus, nitazoxanide); 7: LL-37
  induced expression (Vitamin D, Interferon-γ, 4-phenylbutyrate); 8: Increased ROS
  production (Imiquimod); 9: PI3K/Akt/mTOR pathway inhibition (Baicalin, imatinib,
  nilotinib, ibrutinib, bazedoxifene); 10: Autophagic flux induction (Pasakbumin A,
  fluoxetine); 11: ER stress mediated autophagy induction (Thiostrepton); 12: Depletion
  of p38 MAPK mediated autophagy activation via p38IP and mATG9 (Gefitnib); 13: Autophagy
  genes (ATG16L1 and LC3) upregulation (Loperamide); 14: AMPK activation via inositol
  signaling pathway (Carbamazepine); 15: mTOR independent autophagy formation via
  ATG 12 (Valproic acid); 16: Slow autophagic flux and increased lysozyme acidification
  (Prochlorperazine edisylate), Alphabets (A-H) describes the different pathways—A:
  mTORC1/ULK/ATG13/FIP200 dependent pathway, B: AMPK/TSC/mTORC1 dependent pathway,
  C: PI3KC1a/Akt/TSC/mTORC1 dependent pathway, D: Rag/mTORC1 dependent pathway, E:
  mTOR independent Ca2+/calpain pathway, F: mTOR independent inositol signalling pathway,
  G: mTOR independent JNK1/Beclin1/PI3KC3 pathway, H: mTOR independent cAMP/Ins(1,4,5)P3
  pathway, AMBRA1: Activating molecule in BECN1 regulated autophagy protein 1, AMPK:
  AMP-activated protein kinase, ATG: Autophagy-related genes or proteins, Ca2+: Calcium
  ions, CaMKKβ: Ca2+/calmodulin-dependent protein kinase kinase β, cAMP/Ins(1,4,5)P3:
  Cyclic adenosine monophosphate/inositol (1,4,5)-trisphosphate, cGAS-STING: Cyclic
  GMP-AMP Synthase—simulator of interferon genes, FIP200: focal adhesion kinase family-interacting
  protein of 200 kDa, JNK1: c-Jun N-terminal kinase 1, LC3: Microtubule associated
  protein 1 (MAP1) light chain 3, LL-37: Human cathelicidin, NAD+/NADH: Nicotinamide
  adenine dinucleotide (NAD) + hydrogen (H), NBR1: Neighbor of BRCA1 gene 1, NDP52:
  Nuclear domain 10 protein 52, NOS: Nitric oxide synthase, OPTN: Optineurin, PE:
  phosphatidylethanolamine, PI3KC3 complex: Class III phosphatidylinositol 3-kinase
  (PI3K) complex, PI3KC1a/Akt/TSC/mTORC1: Class 1a phosphoinositide 3-kinase/protein
  kinase B/tuberous sclerosis complex/mTORC1, PI3P: Phosphatidylinositol 3-phosphate,
  PIP2: Phosphatidylinositol bisphosphate, PPARα: Peroxisome proliferation factor-activated
  receptor α, PPARGC1A: Peroxisome proliferator-activated receptor gamma coactivator
  1-alpha, P2RX7: Purinergic Receptor 7, ROS: Reactive oxygen species, Rag/mTORC1:
  Ras-related GTP-binding protein/mammalian target of rapamycin complex 1, SIRT: Sirtuin
  protein, TFEB: Transcription factors EB, ULK1/2: UNC-51-Like Ser/Thr kinase, VPS:
  Vacuolar protein sorting, WIPI2: WD repeat domain phosphoinositide-interacting protein
  2.'
papertitle: Autophagy Induction as a Host-Directed Therapeutic Strategy against Mycobacterium
  tuberculosis Infection.
reftext: Harresh Adikesavalu, et al. Medicina (Kaunas). 2021 Jun;57(6):522.
year: '2021'
doi: 10.3390/medicina57060522
journal_title: Medicina
journal_nlm_ta: Medicina (Kaunas)
publisher_name: MDPI
keywords: Mycobacterium tuberculosis | host-directed therapies | autophagy | adjuvants
automl_pathway: 0.7655903
figid_alias: PMC8224563__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC8224563__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8224563__medicina-57-00522-g001.html
  '@type': Dataset
  description: 'Regulatory mechanism of autophagy pathway and potential targets ofdifferent
    host directed therapeutic drugs. (): Activation, ():inhibition, (): Drug induced
    activation, (): Drug induced inhibition, (): Upregulation, (): Downregulation,
    (): Drug induced upregulation, (): Blocks activation process, Numbers in blue
    boxes indicate drug induced activation of the following processes—1: Increased
    autophagosome formation (SMER 18 & 28, nortriptyline); 2: AMPK activation: (AICAR,
    ornithine, metformin, statins); 3: TFEB signaling upregulation (GSK4112, GW7647,
    trehalose, Wy14643, honokiol, ambroxol); 4: SIRT 1, 3 activator (SRT 1720, resveratrol,
    honokiol); 5: Ca2+—AMPK signaling (GABA, vitamin D, soyabean lectin, isoniazid,
    pyrazinamide, calcimycin); 6: mTOR inhibition (Rapamycin, evorilimus, nitazoxanide);
    7: LL-37 induced expression (Vitamin D, Interferon-γ, 4-phenylbutyrate); 8: Increased
    ROS production (Imiquimod); 9: PI3K/Akt/mTOR pathway inhibition (Baicalin, imatinib,
    nilotinib, ibrutinib, bazedoxifene); 10: Autophagic flux induction (Pasakbumin
    A, fluoxetine); 11: ER stress mediated autophagy induction (Thiostrepton); 12:
    Depletion of p38 MAPK mediated autophagy activation via p38IP and mATG9 (Gefitnib);
    13: Autophagy genes (ATG16L1 and LC3) upregulation (Loperamide); 14: AMPK activation
    via inositol signaling pathway (Carbamazepine); 15: mTOR independent autophagy
    formation via ATG 12 (Valproic acid); 16: Slow autophagic flux and increased lysozyme
    acidification (Prochlorperazine edisylate), Alphabets (A-H) describes the different
    pathways—A: mTORC1/ULK/ATG13/FIP200 dependent pathway, B: AMPK/TSC/mTORC1 dependent
    pathway, C: PI3KC1a/Akt/TSC/mTORC1 dependent pathway, D: Rag/mTORC1 dependent
    pathway, E: mTOR independent Ca2+/calpain pathway, F: mTOR independent inositol
    signalling pathway, G: mTOR independent JNK1/Beclin1/PI3KC3 pathway, H: mTOR independent
    cAMP/Ins(1,4,5)P3 pathway, AMBRA1: Activating molecule in BECN1 regulated autophagy
    protein 1, AMPK: AMP-activated protein kinase, ATG: Autophagy-related genes or
    proteins, Ca2+: Calcium ions, CaMKKβ: Ca2+/calmodulin-dependent protein kinase
    kinase β, cAMP/Ins(1,4,5)P3: Cyclic adenosine monophosphate/inositol (1,4,5)-trisphosphate,
    cGAS-STING: Cyclic GMP-AMP Synthase—simulator of interferon genes, FIP200: focal
    adhesion kinase family-interacting protein of 200 kDa, JNK1: c-Jun N-terminal
    kinase 1, LC3: Microtubule associated protein 1 (MAP1) light chain 3, LL-37: Human
    cathelicidin, NAD+/NADH: Nicotinamide adenine dinucleotide (NAD) + hydrogen (H),
    NBR1: Neighbor of BRCA1 gene 1, NDP52: Nuclear domain 10 protein 52, NOS: Nitric
    oxide synthase, OPTN: Optineurin, PE: phosphatidylethanolamine, PI3KC3 complex:
    Class III phosphatidylinositol 3-kinase (PI3K) complex, PI3KC1a/Akt/TSC/mTORC1:
    Class 1a phosphoinositide 3-kinase/protein kinase B/tuberous sclerosis complex/mTORC1,
    PI3P: Phosphatidylinositol 3-phosphate, PIP2: Phosphatidylinositol bisphosphate,
    PPARα: Peroxisome proliferation factor-activated receptor α, PPARGC1A: Peroxisome
    proliferator-activated receptor gamma coactivator 1-alpha, P2RX7: Purinergic Receptor
    7, ROS: Reactive oxygen species, Rag/mTORC1: Ras-related GTP-binding protein/mammalian
    target of rapamycin complex 1, SIRT: Sirtuin protein, TFEB: Transcription factors
    EB, ULK1/2: UNC-51-Like Ser/Thr kinase, VPS: Vacuolar protein sorting, WIPI2:
    WD repeat domain phosphoinositide-interacting protein 2.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ANGPT1
  - ANGPT2
  - ANGPT4
  - AREG
  - BDNF
  - CSF1
  - EFNA1
  - EFNA2
  - EFNA3
  - EFNA4
  - EFNA5
  - EGF
  - EREG
  - FGF1
  - FGF10
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF2
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FLT3LG
  - HGF
  - IGF1
  - IGF2
  - INS
  - KITLG
  - NGF
  - NTF3
  - NTF4
  - PDGFA
  - PDGFB
  - PDGFC
  - PDGFD
  - PGF
  - TGFA
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - RRAGA
  - RRAGB
  - RRAGC
  - RRAGD
  - AKT1
  - AKT2
  - AKT3
  - NOS1
  - NOS2
  - NOS3
  - MTOR
  - RPTOR
  - TSC2
  - TSC1
  - CCL26
  - ATP8A2
  - APRT
  - MFAP1
  - MAPK8
  - PRKAA1
  - PRKAA2
  - PRKAB1
  - PRKAB2
  - PRKAG1
  - PRKAG2
  - PRKAG3
  - ATG14
  - PIK3R4
  - PIK3C3
  - BECN1
  - UVRAG
  - ATG13
  - ULK1
  - ULK2
  - ATG101
  - MT1JP
  - NCAPG2
  - RB1CC1
  - SIRT3
  - SIRT1
  - MAP1LC3A
  - GTF2H1
  - SQSTM1
  - KHDRBS1
  - NUP62
  - DCTN4
  - CALCOCO2
  - OPTN
  - CAMP
  - P2RX7
---
